Personalis Inc (NAS:PSNL)

$ 5.87 -0.39 (-6.23%) Market Cap: 497.15 Mil Enterprise Value: 431.68 Mil PE Ratio: 0 PB Ratio: 2.49 GF Score: 61/100

Q3 2024 Personalis Inc Earnings Call Transcript
Nov 06, 2024

$5.58 (-1.06%)

Earnings
Q2 2024 Personalis Inc Earnings Call Transcript
Aug 07, 2024

$2.88 (-10.00%)

Earnings
Q1 2024 Personalis Inc Earnings Call Transcript
May 08, 2024

$1.57 (-0.95%)

Earnings
Q4 2023 Personalis Inc Earnings Call Transcript
Feb 28, 2024

$1.46 (-2.67%)

Earnings
Q3 2023 Personalis Inc Earnings Call Transcript
Nov 07, 2023

$0.9628 (-9.17%)

Earnings
Personalis Inc Clinical Update Call Transcript
Oct 24, 2023
Q2 2023 Personalis Inc Earnings Call Transcript
Aug 08, 2023

$1.98 (+4.21%)

Earnings
Q1 2023 Personalis Inc Earnings Call Transcript
May 03, 2023

$2.42 (+10.00%)

Earnings
Q4 2022 Personalis Inc Earnings Call Transcript
Feb 23, 2023

$3.18

Earnings
Q3 2022 Personalis Inc Earnings Call Transcript
Nov 02, 2022

$2.7 (-1.46%)

Earnings
Q2 2022 Personalis Inc Earnings Call Transcript
Aug 03, 2022

$4.48 (+10.07%)

Earnings
Personalis Inc at UBS Global Healthcare Conference Transcript
May 24, 2022
Q1 2022 Personalis Inc Earnings Call Transcript
May 04, 2022

$5.97 (+2.93%)

Earnings
Q4 2021 Personalis Inc Earnings Call Transcript
Feb 24, 2022

$10.04 (+9.61%)

Earnings
Q3 2021 Personalis Inc Earnings Call Transcript
Nov 04, 2021

$21.25 (+6.04%)

Earnings
Personalis Inc Business Update Call Transcript
Sep 20, 2021
Personalis Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 09, 2021
Q2 2021 Personalis Inc Earnings Call Transcript
Aug 04, 2021

$20.23 (+1.35%)

Earnings
Personalis Inc Annual Shareholders Meeting Transcript
May 14, 2021
Q1 2021 Personalis Inc Earnings Call Transcript
May 05, 2021

$21.04 (-2.77%)

Earnings
Q4 2020 Personalis Inc Earnings Call Transcript
Feb 25, 2021

$31.68 (-8.68%)

Earnings
Q3 2020 Personalis Inc Earnings Call Transcript
Nov 05, 2020

$26.77 (+1.48%)

Earnings
Personalis Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 17, 2020
Q2 2020 Personalis Inc Earnings Call Transcript
Aug 06, 2020

$21.66 (-1.63%)

Earnings
Personalis Inc at UBS Global Healthcare Conference (Virtual) Transcript
May 19, 2020
Personalis Inc Annual Shareholders Meeting Transcript
May 15, 2020
Q1 2020 Personalis Inc Earnings Call Transcript
May 07, 2020

$10.34 (-1.15%)

Earnings
Q4 2019 Personalis Inc Earnings Call Transcript
Mar 25, 2020

$7 (+7.53%)

Earnings
Q3 2019 Personalis Inc Earnings Call Transcript
Nov 13, 2019

$10.89 (+6.97%)

Earnings
Q2 2019 Personalis Inc Earnings Call Transcript
Aug 13, 2019

$19.71 (+2.39%)

Earnings

Q3 2024 Personalis Inc Earnings Call Transcript

Nov 06, 2024 / 10:00PM GMT

Release Date Price: $5.58 (-1.06%)

Transcript 10-Q8-K

Operator

Good afternoon, everyone and welcome to personnel. Third quarter, 2024 earnings conference call.

All participants. I listen-only mode the question and answer session will follow the formal presentation.

If anyone should require operator assistance during the conference, please press the star key and then zero on your telephone keypad.

Please note that this event is being recorded.

I'd now like to turn the conference over to Caroline corner. Please go ahead ma'am.

Caroline Corner

Clearpoint Neuro Inc - Investor Relations

Thank you operator. Welcome to personal analysis. Third quarter 2024 earnings call. Joining today's call are Chris Hall, Chief Executive Officer and President Aaron Tsha Bana, chief financial and Chief Operating Officer and Rich Chan, Chief Medical Officer and EVP R&D. All statements made on this call that do not relate to matters of historical facts should be considered forward-looking statements within the meanings of the US security laws. For example, any statements regarding trends and expectations

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.